Showing results (321-330 of 387) with videos related to
Sort By:
Pageof 39
Ejhaem|July 18, 2022
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphomaLoretta J Nastoupil, John Kuruvilla, Julio C Chavez, et al.Blood Advances|September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphomaColleen A Ramsower, George Wright, Hongli Li, et al.American Journal of Hematology|November 20, 2024
Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical PilotThomas E Witzig, William R Taylor, Douglas W Mahoney, et al.American Journal of Hematology|April 27, 2013
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphomaThomas E Witzig, Gregory A Wiseman, Matthew J Maurer, et al.Leukemia|March 7, 2020
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCLKeenan T Hartert, Kerstin Wenzl, Jordan E Krull, et al.JAMA Oncology|October 6, 2022
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration StatusJithma P Abeykoon, Karen L Rech, Jason R Young, et al.Cell Reports. Medicine|March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironmentsJordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.Blood|March 28, 2009
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasonePrashant Kapoor, Shaji Kumar, Rafael Fonseca, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphomaCarrie A Thompson, Herve Ghesquieres, Matthew J Maurer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2021
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412Grzegorz S Nowakowski, Fangxin Hong, David W Scott, et al.Pageof 39